InsidersTradesSigma
Total declarations
Company
▲ Purchases (22 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by COMMODORE CAPITAL LP. Insider active across 1 company, notably Satsuma Pharmaceuticals, Inc.. Aggregated, 22 disclosures have been recorded. Breakdown: 22 buys · 0 sell. Total volume traded: €3.2m. History available since 15 October 2021. The latest transaction was disclosed on 24 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
2,922 shares@ US$5.420.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001545:0
Ideal exit: 21 Aug 2022 (T+270)
2,922 shares@ US$5.420.9% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001545
Ideal exit: 21 Aug 2022 (T+270)
3,225 shares@ US$5.440.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001523:0
Ideal exit: 16 Aug 2022 (T+270)
3,225 shares@ US$5.441.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001523
Ideal exit: 16 Aug 2022 (T+270)
9,622 shares@ US$5.853.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001471
Ideal exit: 7 Aug 2022 (T+270)
9,622 shares@ US$5.851.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001471:0
Ideal exit: 7 Aug 2022 (T+270)
560 shares@ US$5.990.1% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001460:0
Ideal exit: 5 Aug 2022 (T+270)
560 shares@ US$5.990.2% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001460
Ideal exit: 5 Aug 2022 (T+270)
1,400 shares@ US$5.880.2% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001450:0
Ideal exit: 1 Aug 2022 (T+270)
1,400 shares@ US$5.880.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001450
Ideal exit: 1 Aug 2022 (T+270)
8,880 shares@ US$5.641.4% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001430:0
Ideal exit: 30 Jul 2022 (T+270)
8,880 shares@ US$5.642.7% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001430
Ideal exit: 30 Jul 2022 (T+270)
44,651 shares@ US$5.7113.7% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001420
Ideal exit: 26 Jul 2022 (T+270)
44,651 shares@ US$5.716.8% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001420:0
Ideal exit: 26 Jul 2022 (T+270)
39,581 shares@ US$5.4511.7% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001408
Ideal exit: 24 Jul 2022 (T+270)
39,581 shares@ US$5.455.8% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001408:0
Ideal exit: 24 Jul 2022 (T+270)
32,816 shares@ US$5.404.8% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001391:0
Ideal exit: 18 Jul 2022 (T+270)
32,816 shares@ US$5.409.6% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001391
Ideal exit: 18 Jul 2022 (T+270)
87,580 shares@ US$5.0712.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001384:0
Ideal exit: 16 Jul 2022 (T+270)
87,580 shares@ US$5.0723.9% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001384
Ideal exit: 16 Jul 2022 (T+270)
126,000 shares@ US$4.8332.9% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001373
Ideal exit: 12 Jul 2022 (T+270)
126,000 shares@ US$4.8316.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-21-001373:0
Ideal exit: 12 Jul 2022 (T+270)
22 of 22 declarations
About COMMODORE CAPITAL LP
COMMODORE CAPITAL LP is an investor in Satsuma Pharmaceuticals, Inc.
